AG
ASMB icon

Aperio Group’s Assembly Biosciences ASMB Stock Holding History

Aperio Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$80K Sell
1,110
-157
-12% -$18.4K ﹤0.01% 2389
2020
Q3 		$250K Buy
1,267
+114
+10% +$28.7K ﹤0.01% 2140
2020
Q2 		$323K Buy
1,153
+313
+37% +$73K ﹤0.01% 1988
2020
Q1 		$149K Buy
+840
New +$180K ﹤0.01% 2147
2019
Q3 		– Sell
-336
Closed -$55K – 2336
2019
Q2 		$55K Buy
+336
New +$63.9K ﹤0.01% 2515

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Aperio Group's ASMB Position: Q4 2020 in Review

Aperio Group reduced its Assembly Biosciences (ASMB) stake by 12% in Q4 2020, selling an estimated $18.4K and leaving 1,110 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Aperio Group first reported a position in ASMB in Q2 2019 and has held it in 5 quarters since. The position peaked at $323K in Q2 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Aperio Group held 1,110 shares of Assembly Biosciences worth $80K as of Q4 2020.
  • Aperio Group sold 157 Assembly Biosciences shares in Q4 2020, an estimated $18.4K.
  • Assembly Biosciences made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2389 holding.
  • Aperio Group first reported a position in Assembly Biosciences in Q2 2019 and has held it in 5 quarters since.
  • Aperio Group's Assembly Biosciences position peaked at $323K in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.